Free Trial

Bellevue Healthcare (BBH) Competitors

Bellevue Healthcare logo
GBX 139.60 -0.60 (-0.43%)
As of 02/21/2025 12:35 PM Eastern

BBH vs. JGGI, 3IN, PHLL, RCP, ABDN, MNKS, BUR, SSON, EMG, and HGT

Should you be buying Bellevue Healthcare stock or one of its competitors? The main competitors of Bellevue Healthcare include JPMorgan Global Growth & Income (JGGI), 3i Infrastructure (3IN), Petershill Partners (PHLL), RIT Capital Partners (RCP), abrdn (ABDN), Monks (MNKS), Burford Capital (BUR), Smithson Investment Trust (SSON), Man Group (EMG), and HgCapital Trust (HGT). These companies are all part of the "asset management" industry.

Bellevue Healthcare vs.

JPMorgan Global Growth & Income (LON:JGGI) and Bellevue Healthcare (LON:BBH) are both financial services companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, community ranking, risk, institutional ownership and earnings.

JPMorgan Global Growth & Income pays an annual dividend of GBX 23 per share and has a dividend yield of 3.9%. Bellevue Healthcare pays an annual dividend of GBX 6 per share and has a dividend yield of 4.3%. JPMorgan Global Growth & Income pays out 19.0% of its earnings in the form of a dividend. Bellevue Healthcare pays out -91.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Bellevue Healthcare is clearly the better dividend stock, given its higher yield and lower payout ratio.

14.9% of JPMorgan Global Growth & Income shares are owned by institutional investors. Comparatively, 40.6% of Bellevue Healthcare shares are owned by institutional investors. 7.9% of JPMorgan Global Growth & Income shares are owned by insiders. Comparatively, 0.1% of Bellevue Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, JPMorgan Global Growth & Income had 2 more articles in the media than Bellevue Healthcare. MarketBeat recorded 2 mentions for JPMorgan Global Growth & Income and 0 mentions for Bellevue Healthcare. JPMorgan Global Growth & Income's average media sentiment score of 0.96 beat Bellevue Healthcare's score of 0.00 indicating that JPMorgan Global Growth & Income is being referred to more favorably in the media.

Company Overall Sentiment
JPMorgan Global Growth & Income Positive
Bellevue Healthcare Neutral

Bellevue Healthcare has a net margin of 169.10% compared to JPMorgan Global Growth & Income's net margin of 94.75%. JPMorgan Global Growth & Income's return on equity of 22.97% beat Bellevue Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
JPMorgan Global Growth & Income94.75% 22.97% 10.62%
Bellevue Healthcare 169.10%-4.48%N/A

JPMorgan Global Growth & Income has higher revenue and earnings than Bellevue Healthcare. Bellevue Healthcare is trading at a lower price-to-earnings ratio than JPMorgan Global Growth & Income, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
JPMorgan Global Growth & Income£660.56M4.64£625.87M£121.354.90
Bellevue Healthcare-£9.60M-35.86-£16.23M-£6.57-21.23

Bellevue Healthcare received 109 more outperform votes than JPMorgan Global Growth & Income when rated by MarketBeat users. Likewise, 68.52% of users gave Bellevue Healthcare an outperform vote while only 66.67% of users gave JPMorgan Global Growth & Income an outperform vote.

CompanyUnderperformOutperform
JPMorgan Global Growth & IncomeOutperform Votes
2
66.67%
Underperform Votes
1
33.33%
Bellevue HealthcareOutperform Votes
111
68.52%
Underperform Votes
51
31.48%

Summary

JPMorgan Global Growth & Income beats Bellevue Healthcare on 10 of the 16 factors compared between the two stocks.

Get Bellevue Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BBH vs. The Competition

MetricBellevue HealthcareAsset Management IndustryFinancial SectorLON Exchange
Market Cap£344.05M£1.23B£4.25B£2.63B
Dividend Yield3.82%4.47%4.22%4.98%
P/E Ratio-21.2326.9916.05163.28
Price / Sales-35.862,363.901,767.21312,084.15
Price / CashN/A60.5748.8028.02
Price / Book0.931.153.405.14
Net Income-£16.23M£256.58M£1.27B£5.73B
7 Day Performance-2.65%-0.31%-0.17%-0.99%
1 Month Performance-4.38%0.63%1.82%-0.81%
1 Year Performance-6.93%10.15%14.64%39.26%

Bellevue Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BBH
Bellevue Healthcare
N/AGBX 139.60
-0.4%
N/A-6.5%£344.05M£-9,595,061.74-21.23N/A
JGGI
JPMorgan Global Growth & Income
N/AGBX 607
+0.2%
N/A+11.5%£2.99B£345.48M697.70N/A
3IN
3i Infrastructure
N/AGBX 323.50
+0.6%
N/A-3.0%£2.98B£374M851.32N/A
PHLL
Petershill Partners
1.8793 of 5 stars
GBX 269
flat
GBX 245.33
-8.8%
+51.8%£2.91B£578.70M1,169.57N/AGap Up
RCP
RIT Capital Partners
N/AGBX 1,972
flat
N/A+7.5%£2.84B£314.90M1,217.2862
ABDN
abrdn
1.22 of 5 stars
GBX 155.80
-1.2%
GBX 155
-0.5%
-3.5%£2.77B£1.41B916.474,719News Coverage
MNKS
Monks
N/AGBX 1,344
+0.4%
N/A+24.6%£2.71B£419.32M755.06N/A
BUR
Burford Capital
N/AGBX 1,204
+1.2%
GBX 1,600
+32.9%
+0.7%£2.64B£1.17B891.85140Positive News
SSON
Smithson Investment Trust
N/AGBX 1,540
-0.1%
N/A+14.1%£2.50BN/A678.41N/ANews Coverage
EMG
Man Group
3.3343 of 5 stars
GBX 208.40
-1.5%
GBX 291.17
+39.7%
-10.8%£2.40B£1.40B1,042.001,790News Coverage
HGT
HgCapital Trust
N/AGBX 521
+0.4%
N/A+21.5%£2.38B£255.96M1,042.00N/ANews Coverage
Positive News

Related Companies and Tools


This page (LON:BBH) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners